Effectiveness of a projection-based augmented reality exposure system in treating cockroach phobia: study protocol of a randomised controlled trial

Abstract

BackgroundDespite being the treatment of choice for phobic disorders, in vivo exposure treatment (IVET) presents some important limitations related mainly to low acceptance and high drop-out rates. Augmented reality (AR) technologies can help to overcome these limitations. Evidence supports the use of AR in exposure treatment for small animal phobia. A new projection-based AR exposure treatment system (P-ARET) that offers the possibility of projecting the animals in a natural and non-intrusive environment has been developed. There are no randomised controlled trials (RCTs) available that have tested the efficacy of this system in cockroach phobia. This paper aims to present the protocol of an RCT that evaluates the efficacy of the P-ARET, versus an IVET group and a waiting list control group (WL), in carrying out exposure treatment for cockroach phobia.Methods/designParticipants will be randomly allocated to one of three conditions: (1) P-ARET, (2) IVET and (3) WL. Both treatment conditions will follow the ‘one-session treatment’ guidelines. As a diagnostic measure, the Anxiety Disorders Interview Schedule for Diagnostic and Statistical Manual for Mental Health Disorders-Version 5 will be used. The Behavioral Avoidance Test will be used as the primary outcome measure. Secondary outcome measures will include an attentional biases task (measured using eye-tracking technology), the Fear of Cockroaches Questionnaire, Cockroach Phobia Beliefs Questionnaire, Fear and Avoidance Scales, Beck Depression Inventory second edition, Disgust Propensity and Sensitivity Scale-Revised-12, State-Trait Anxiety Inventory, Clinician Severity Scale, and Expectation and Satisfaction with the Treatment Scale. The evaluation protocol will include pretreatment and post-treatment evaluations and 1, 6 and 12 months of follow-ups. Intention-to-treat and per-protocol analyses will be performed.Ethics and disseminationThis study has been approved by the Ethics Committee of Universitat Jaume I (Castellón, Spain; 13 December 2019). The results of the presented RCT will be disseminated in presentations at international scientific meetings and peer-reviewed scientific journals.Trial registration numberNCT04563390.

Improving the efficacy of exposure therapy using projection-based augmented reality for the treatment of cockroach phobia: a randomised clinical trial protocol

“…This work is part of a research project (Ministerio de Ciencia, Innovación y Universidades (Spain) (Programa Estatal I+D+ i RTI2018-100993-B-I00) composed by two RCTs. The first RCT study in the project focuses on analysing the effectiveness of the exposure treatment using AR compared with the treatment of choice for SP (in vivo exposure) and with a control group (waiting list) 27. The study presented in this manuscript is focused on analysing the potential of the AR system, evaluating its efficacy and feasibility, and comparing two treatment groups that use the AR exposure treatment, but varying the number of stimuli presented to the patient (one SS vs MS).…”

“…The first RCT study in the project focuses on analysing the effectiveness of the exposure treatment using AR compared with the treatment of choice for SP (in vivo exposure) and with a control group (waiting list). 27 The study presented in this manuscript is focused on analysing the potential of the AR system, evaluating its efficacy and feasibility, and comparing two treatment groups that use the AR exposure treatment, but varying the number of stimuli presented to the patient (one SS vs MS). Both studies are completely independent and have separate trial participants.…”